VEGFA and breast carcinoma: Here, we employed this imaging approach in conjunction with multi-parametric histological validation to determine the ability of MRI to “phenotype” VEGF-induced changes in the in vivo tumor microenvironment of noninvasive MCF-7 and invasive MDA-MB-231 human breast cancer xenografts engineered to overexpress human VEGF-A.